SCHEMBL17900520

SCHEMBL17900520

CCCC[C@@H](CC(C)P(C1CCCCC1)C1CCCCC1)P(c1ccccc1)c1ccccc1

nearest known ligand 0.31

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
CTSK P43235 1/20 0.31
CNR2 P34972 1/20 0.30
ROCK2 O75116 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15443869 1.00 CTSK (0.31) CTSKCNR2ROCK2
SCHEMBL16348703 0.73 PKM (0.34) ROCK2
SCHEMBL10773183 0.73 CYP1A2 (0.39) CTSK
SCHEMBL17900527 0.72 PSEN1 (0.35) CTSK
SCHEMBL14148643 0.70 CSNK1E (0.38) CNR2
SCHEMBL6568659 0.70 POLB (0.39) CTSKCNR2
SCHEMBL17750751 0.70 POLB (0.39) CTSKCNR2
SCHEMBL16199147 0.70 POLB (0.39) CTSKCNR2
SCHEMBL14434711 0.68 CSNK1E (0.39) CNR2
Hydrochloric Acid SCHEMBL19809583 0.68 POLB (0.38) CTSKCNR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160194331-A1 METHOD FOR PRODUCING SPIROOXINDOLE DERIVATIVE DAIICHI SANKYO CO LTD (JP) 2016-07-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160194331-A1 METHOD FOR PRODUCING SPIROOXINDOLE DERIVATIVE MDM2, TP53, RB1 CTSK 2697/4885CNR2 4281/4885ROCK2 2184/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.